Treatment Outcomes of Pediatric Patients With Ewing Sarcoma in a War-Torn Nation: A Single-Institute Experience From Iraq
Author(s) -
Sazgar Star Majeed,
Hawzheen A. Muhammad,
Jalil S. Ali,
Hassanain H. Khudhair,
Ayah Said,
Shkar Othman Arif,
Karzan Marif Murad,
Ali H. Gendari,
Bamo M. Muhsin,
Shwan Ali Mohammed,
Layth MulaHussain
Publication year - 2019
Publication title -
journal of global oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.002
H-Index - 17
ISSN - 2378-9506
DOI - 10.1200/jgo.18.00122
Subject(s) - medicine , sarcoma , presentation (obstetrics) , ewing's sarcoma , pelvis , surgery , retrospective cohort study , radiation therapy , medical record , chemotherapy , pediatrics , pathology
Ewing sarcoma (ES) is a relatively rare, highly malignant tumor of the musculoskeletal system. It is the second most common malignant bone tumor in children and adolescents in the age group of 5 to 20 years. The aim of this study was to identify the treatment outcomes of pediatric patients with ES in Sulaimani governorate, Iraq.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom